About Taurus Biosciences
Taurus Biosciences is a Healthcare company based in San Diego (United States) founded in 2018, and was acquired by Ligand Pharmaceuticals in September 2020. Novel cow antibodies are developed for therapeutic applications. Taurus Biosciences offers products and services including OmniRat, OmniMouse, OmniChicken, Omni dAb, and Bispecific Platforms. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified. Its legal entity is OmniAb, Inc. Its competitors include Avidity Biosciences, Sutro Biopharma and Vividion Therapeutics; 3 of its 3 listed competitors have raised funding.
Company details
Taurus Biosciences was founded in 2018 in San Diego, United States, within the biotechnology sector. Novel cow antibodies are discovered and developed, with intellectual property held on ultralong CDR3s and humanized versions. These engineered antibodies are applied to bind multiple antigens and target ion channels for autoimmune disease and cancer therapeutics. Support is provided for the study and development of cow-based monoclonal antibodies.
- Headquarters San Diego, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website taurusbiosci.com
- Social LinkedIn X
- Acquired by Ligand Pharmaceuticals (Sep 2020)
- Legal Name Omniab, Inc.
- Investors
- Acquired byLigand Pharmaceuticals
(Sep 2020)
Products & Services of Taurus Biosciences
Taurus Biosciences offers a comprehensive portfolio of products and services, including OmniRat, OmniMouse, OmniChicken, Omni dAb, and Bispecific Platforms.
Platform for generating human antibodies using transgenic rats
Transgenic mouse system for antibody discovery and optimization
Transgenic chicken for producing humanized single-domain antibodies
Technology for diverse antibody repertoires against conserved antigens
Tools for developing bispecific antibodies for therapeutic applications
Investors in Taurus Biosciences
Taurus Biosciences has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Ligand Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Pharmaceutical drugs are manufactured and developed in the United States. | 1987 | ligand.com | San Diego, United States |
Investor details for Taurus Biosciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Taurus Biosciences
2 dated milestones of Taurus Biosciences across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Taurus Biosciences is founded.
- Exit Acquired by Ligand Pharmaceuticals.
Competitors of Taurus Biosciences
Taurus Biosciences has 3 listed competitors in our database, 3 of them funded. They include Avidity Biosciences, Sutro Biopharma and Vividion Therapeutics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform |
Detailed competitors of Taurus Biosciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Taurus Biosciences (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Taurus Biosciences
Complete news archive for Taurus Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Taurus Biosciences
Taurus Biosciences was founded in 2018.
Taurus Biosciences is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Taurus Biosciences was founded in 2018 in San Diego, United States, within the biotechnology sector. Novel cow antibodies are discovered and developed, with intellectual property held on ultralong CDR3s and humanized versions. These engineered antibodies are applied to bind multiple antigens and target ion channels for autoimmune disease and cancer therapeutics. Support is provided for the study and development of cow-based monoclonal antibodies.
Taurus Biosciences's top competitors include Sutro Biopharma, Avidity Biosciences and Vividion Therapeutics.
Taurus Biosciences offers OmniRat, OmniMouse, OmniChicken, Omni dAb, and Bispecific Platforms.
Taurus Biosciences has 1 investor. Key investors include Ligand Pharmaceuticals.
Taurus Biosciences operates through Omniab, Inc..
Yes. Taurus Biosciences was acquired by Ligand Pharmaceuticals in September 2020.